WO2013171446A2 - Saliva testing - Google Patents

Saliva testing Download PDF

Info

Publication number
WO2013171446A2
WO2013171446A2 PCT/GB2013/000226 GB2013000226W WO2013171446A2 WO 2013171446 A2 WO2013171446 A2 WO 2013171446A2 GB 2013000226 W GB2013000226 W GB 2013000226W WO 2013171446 A2 WO2013171446 A2 WO 2013171446A2
Authority
WO
WIPO (PCT)
Prior art keywords
pad
sample
test
saliva
filter pad
Prior art date
Application number
PCT/GB2013/000226
Other languages
French (fr)
Other versions
WO2013171446A3 (en
Inventor
Peter William Dettmar
Jonathan Richard Flint
Original Assignee
Technostics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technostics Limited filed Critical Technostics Limited
Priority to GB1422440.6A priority Critical patent/GB2518311B/en
Priority to CN201380025829.0A priority patent/CN104471399B/en
Publication of WO2013171446A2 publication Critical patent/WO2013171446A2/en
Publication of WO2013171446A3 publication Critical patent/WO2013171446A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045Devices for taking samples of body liquids
    • A61B10/0051Devices for taking samples of body liquids for taking saliva or sputum samples
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B2010/0003Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements including means for analysis by an unskilled person

Definitions

  • the present invention relates to devices and methods for carrying out assays on saliva samples and in particular to lateral flow devices and methods.
  • Lateral flow devices are used in assays and are simple devices intended to detect the presence (or absence) of a target in a sample.
  • the lateral flow devices may be used in a wide variety of applications including pregnancy tests, HIV tests and malaria tests.
  • the test can be applied to ,for instance, urine, saliva, blood or stool samples.
  • EP1277053 discloses a method and device for diagnostic testing of an oral fluid, including saliva. This patent is concerned with a problem encountered with the testing of saliva which is that the saliva sample does not run along the lateral flow test strip. The inventors of EP 1277053 believed that this was due to the relatively high concentrations of mucin and other viscous, proteinaceous materials in the specimen. The inventors proposed including in the device a pad having deposited thereon a salt or other known mucinolytic substance known to break down and lower the viscosity of mucin-containing fluids. The pad is composed of a glass of fibre matrix which provides means for filtering the disassociated proteinaceous and other particulate material from the specimen. The device is stated to allow convenient and rapid testing of a relatively small saliva sample without any need to pre-treat the saliva in order to enable its migration along the test strip.
  • the fibre pad specified in EP1277053 comprises a die-cut portion of a commercially available glass fibre material having a thickness of about 0.2 mm.
  • the pad is placed on a conjugate pad which has a detector reagent deposited thereon.
  • the saliva specimen is placed on the glass fibre salt pad which breaks down mucin substances which are subsequently filtered by the glass fibres in the salt pad as well as in the underlying glass fibre sample pad.
  • the specimen sample then passes through the conjugate pad where a chemical reaction begins if the analyte is present in the specimen.
  • the specimen sample then passes into capture zones where the test result can be read.
  • the inventors of the present invention have discovered that, for the purposes of certain saliva assays, including a pepsin assay, the saliva runs along the lateral flow test strip sufficiently well to enable test results to be obtained. However in perhaps about 10% of tests the saliva does not run sufficiently well. The reason for this is not clear. However the inventors have discovered that the use of a relatively thick filter, compared to that suggested in EP1277053, enables the saliva to run sufficiently well for meaningful test results to be obtained. Accordingly it is not necessary to have the saliva pass through a pad which is loaded with a material capable of dissociating proteinaceous materials, for example, a salt.
  • a device for testing an oral fluid such as saliva comprising an absorbent lateral flow test strip having a sample portion for receiving a sample to be tested and a test portion for visualising the test results, the sample portion including a filter pad through which, in use the saliva passes before reaching the test portion, the filter pad having a thickness of at least 0.5 mm.
  • the present invention also provides a method for carrying out a diagnostic test of an oral fluid specimen, the method comprising providing a device as claimed in any of the preceding claims, depositing an oral fluid specimen on the sample portion and visualising the test results provided on the test portion.
  • the device includes a housing accommodating a diagnostic strip providing said sample and test portion.
  • the sample portion is located at one end of the diagnostic strip.
  • an absorbent portion is located at the other end of the diagnostic strip.
  • the filter pad is a binder-free fibre pad. More preferably the fibre pad is a glass fibre pad, most preferably a micro-glass pad.
  • the fibre pad is formed from a borosilicate micro-glass.
  • the sample portion includes a backing substrate to which the fibre pad is adhered.
  • the backing substrate is an adhesive polystyrene.
  • the thickness of the filter pad is at least 0.7 mm, more preferably between 0.75 mm and 1 mm.
  • Figure 1 shows two lateral flow devices (LFD), the upper LFD not including a filter pad and the lower LFD including a filter pad; and
  • FIG. 2 shows LFDs as in Figure 1 but without their housings.
  • lateral flow devices 1 comprise a lateral flow assay housed within a plastic housing 3 including a sample well 5 for receiving a saliva specimen.
  • a diagnostic strip 7 accommodated within the housing comprises a sample reception portion, a test portion for visualising the test results and an absorbent portion at the end remote from the sample reception portion.
  • a binder-free borosilicate micro-glass fibre pad is located directly beneath the sample well 5 and adhered to an adhesive polystyrene backing substrate.
  • the micro-glass fibre pad has a basis weight of 120.4 gm 2 , a thickness 0.85 mm and a Frazier permeability of 75.2 L/m 2 /sec.
  • An example of a suitable fibre pad is a Grade 142 pad made by Ahlstrom.
  • the fibre pad facilitates the slow filtration, transition and migration of the sample to the adjacent glass fibre conjugate pad, with which it is in communication.
  • the resultant "treated" saliva rehydrates the immobilised polystyrene labels following which there is migration to the nitrocellulose membrane test region.
  • any particulates are filtered out by sized selection. Transition of other salivary components is regulated and the treated sample is slowly and consistently released on to the conjugate pad. Upon transition to the test region and ultimately the absorbent zone, the saliva is drawn through by continued capillary action. It is believed that the pad sufficiently modities the sample such that those of "problematic" individuals are regulated to behave and therefore flow through the interstitial spaces of the membranes in the same manner as for a "non-problematic" specimen, resulting in identical assay performance.
  • Figure 1 shows the results of an assay of the saliva of a "problematic" specimen. It can be seen that, in the other LFD, no control line appears in the window 7. In Figure 2, which shows the same LFDs but with the housings removed, it can be seen that, in the upper LFD, the 80 ⁇ saliva sample has agglutinated and not flowed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

The present invention relates to a device for testing an oral fluid such as saliva and methods of using said device, the device comprising an absorbent lateral test strip having a sample portion for receiving a sample to be tested and a test portion for visualising the test results, the sample portion including a filter pad through which, in use, the saliva passes before reaching the test portion, the filter pad having a thickness of at least 0.5 mm.

Description

SALIVA TESTING
FIELD OF THE INVENTION
The present invention relates to devices and methods for carrying out assays on saliva samples and in particular to lateral flow devices and methods.
BACKGROUND TO THE INVENTION
Lateral flow devices are used in assays and are simple devices intended to detect the presence (or absence) of a target in a sample. The lateral flow devices may be used in a wide variety of applications including pregnancy tests, HIV tests and malaria tests. The test can be applied to ,for instance, urine, saliva, blood or stool samples.
EP1277053 discloses a method and device for diagnostic testing of an oral fluid, including saliva. This patent is concerned with a problem encountered with the testing of saliva which is that the saliva sample does not run along the lateral flow test strip. The inventors of EP 1277053 believed that this was due to the relatively high concentrations of mucin and other viscous, proteinaceous materials in the specimen. The inventors proposed including in the device a pad having deposited thereon a salt or other known mucinolytic substance known to break down and lower the viscosity of mucin-containing fluids. The pad is composed of a glass of fibre matrix which provides means for filtering the disassociated proteinaceous and other particulate material from the specimen. The device is stated to allow convenient and rapid testing of a relatively small saliva sample without any need to pre-treat the saliva in order to enable its migration along the test strip.
The fibre pad specified in EP1277053 comprises a die-cut portion of a commercially available glass fibre material having a thickness of about 0.2 mm. The pad is placed on a conjugate pad which has a detector reagent deposited thereon. The saliva specimen is placed on the glass fibre salt pad which breaks down mucin substances which are subsequently filtered by the glass fibres in the salt pad as well as in the underlying glass fibre sample pad. The specimen sample then passes through the conjugate pad where a chemical reaction begins if the analyte is present in the specimen. The specimen sample then passes into capture zones where the test result can be read.
The inventors of the present invention have discovered that, for the purposes of certain saliva assays, including a pepsin assay, the saliva runs along the lateral flow test strip sufficiently well to enable test results to be obtained. However in perhaps about 10% of tests the saliva does not run sufficiently well. The reason for this is not clear. However the inventors have discovered that the use of a relatively thick filter, compared to that suggested in EP1277053, enables the saliva to run sufficiently well for meaningful test results to be obtained. Accordingly it is not necessary to have the saliva pass through a pad which is loaded with a material capable of dissociating proteinaceous materials, for example, a salt.
STATEMENTS OF THE INVENTION
According to the present invention there is provided a device for testing an oral fluid such as saliva, the device comprising an absorbent lateral flow test strip having a sample portion for receiving a sample to be tested and a test portion for visualising the test results, the sample portion including a filter pad through which, in use the saliva passes before reaching the test portion, the filter pad having a thickness of at least 0.5 mm.
The present invention also provides a method for carrying out a diagnostic test of an oral fluid specimen, the method comprising providing a device as claimed in any of the preceding claims, depositing an oral fluid specimen on the sample portion and visualising the test results provided on the test portion.
Preferably, the device includes a housing accommodating a diagnostic strip providing said sample and test portion. Preferably, the sample portion is located at one end of the diagnostic strip.
Preferably, an absorbent portion is located at the other end of the diagnostic strip. Preferably, the filter pad is a binder-free fibre pad. More preferably the fibre pad is a glass fibre pad, most preferably a micro-glass pad.
Preferably, the fibre pad is formed from a borosilicate micro-glass.
Preferably, the sample portion includes a backing substrate to which the fibre pad is adhered. More preferably, the backing substrate is an adhesive polystyrene.
Preferably the thickness of the filter pad is at least 0.7 mm, more preferably between 0.75 mm and 1 mm.
BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying drawings are as follows: Figure 1 shows two lateral flow devices (LFD), the upper LFD not including a filter pad and the lower LFD including a filter pad; and
Figure 2 shows LFDs as in Figure 1 but without their housings. DETAILED DESCRIPTION OF THE INVENTION
Referring to Figure 1 of the accompanying drawings, lateral flow devices 1 comprise a lateral flow assay housed within a plastic housing 3 including a sample well 5 for receiving a saliva specimen. A diagnostic strip 7 accommodated within the housing comprises a sample reception portion, a test portion for visualising the test results and an absorbent portion at the end remote from the sample reception portion.
At the sample end of the lower LFD, a binder-free borosilicate micro-glass fibre pad is located directly beneath the sample well 5 and adhered to an adhesive polystyrene backing substrate. The micro-glass fibre pad has a basis weight of 120.4 gm2, a thickness 0.85 mm and a Frazier permeability of 75.2 L/m2/sec. An example of a suitable fibre pad is a Grade 142 pad made by Ahlstrom.
The fibre pad facilitates the slow filtration, transition and migration of the sample to the adjacent glass fibre conjugate pad, with which it is in communication. The resultant "treated" saliva rehydrates the immobilised polystyrene labels following which there is migration to the nitrocellulose membrane test region.
As the saliva migrates through the fibre pad via capillary action, any particulates are filtered out by sized selection. Transition of other salivary components is regulated and the treated sample is slowly and consistently released on to the conjugate pad. Upon transition to the test region and ultimately the absorbent zone, the saliva is drawn through by continued capillary action. It is believed that the pad sufficiently modities the sample such that those of "problematic" individuals are regulated to behave and therefore flow through the interstitial spaces of the membranes in the same manner as for a "non-problematic" specimen, resulting in identical assay performance. Figure 1 shows the results of an assay of the saliva of a "problematic" specimen. It can be seen that, in the other LFD, no control line appears in the window 7. In Figure 2, which shows the same LFDs but with the housings removed, it can be seen that, in the upper LFD, the 80 μΐ saliva sample has agglutinated and not flowed.

Claims

1. A device for testing an oral fluid such as saliva, the device comprising an absorbent lateral test strip having a sample portion for receiving a sample to be tested and a test portion for visualising the test results, the sample portion including a filter pad through which, in use, the saliva passes before reaching the test portion, the filter pad having a thickness of at least 0.5 mm.
2. A device according to claim 1 and including a housing accommodating a diagnostic strip providing said sample and test portion.
3. A device according to claim 2, wherein the sample portion is located at one end of the diagnostic strip.
4.' A device according to claim 2 or claim 3, wherein an absorbent portion is located at the other end of the diagnostic strip.
5. A device according to any of the preceding claims, wherein the filter pad is a binder-free fibre pad.
6. A device according to claim 5, wherein binder-free fibre pad is formed from a micro-glass pad.
7. A device according to claim 6, wherein the binder-free fibre pad is a borosilicate micro-glass.
8. A device according to any of the preceding claims, wherein the sample portion includes a backing substrate to which the fibre pad is adhered.
9. A device according to claim 8, wherein the backing substrate is an adhesive polystyrene.
10. A device according to any of the preceding claims, wherein the thickness of the filter pad is at least 0.7 mm.
11. A device according to claim 10, wherein the filter pad has a thickness between 0.75 mm 1 mm. 12 A device according to Claim 1 and substantially as described herein. 13. A device for testing an oral fluid such as saliva, the device being substantially as described herein with reference to the accompanying drawings. 14. A method for carrying out a diagnostic test of an oral fluid specimen, the method comprising providing a device as claimed in any of the preceding claims, depositing an oral fluid specimen on the sample portion and visualising the test results provided on the test portion.
PCT/GB2013/000226 2012-05-17 2013-05-17 Saliva testing WO2013171446A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1422440.6A GB2518311B (en) 2012-05-17 2013-05-17 Saliva testing
CN201380025829.0A CN104471399B (en) 2012-05-17 2013-05-17 Device for saliva testing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1208663.3A GB201208663D0 (en) 2012-05-17 2012-05-17 Saliva testing
GB1208663.3 2012-05-17

Publications (2)

Publication Number Publication Date
WO2013171446A2 true WO2013171446A2 (en) 2013-11-21
WO2013171446A3 WO2013171446A3 (en) 2014-01-09

Family

ID=46458970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2013/000226 WO2013171446A2 (en) 2012-05-17 2013-05-17 Saliva testing

Country Status (3)

Country Link
CN (1) CN104471399B (en)
GB (2) GB201208663D0 (en)
WO (1) WO2013171446A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1277053A1 (en) 2000-04-19 2003-01-22 Varian, Inc. Device and process for lateral flow saliva testing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92882C (en) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Disposable test strip and process for its manufacture
WO2000007015A1 (en) * 1998-07-29 2000-02-10 Syntron Bioresearch, Inc. Immunoassay device
AU2002225017B2 (en) * 2001-01-15 2006-07-06 Dsm Ip Assets B.V. Test device
US7772007B2 (en) * 2004-04-02 2010-08-10 Cholestech Corporation Assay device for direct measurement of LDL cholesterol
EP1758448A4 (en) * 2004-06-02 2009-11-04 Relia Diagnostic Systems Llc Quantitative lateral flow system and assay

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1277053A1 (en) 2000-04-19 2003-01-22 Varian, Inc. Device and process for lateral flow saliva testing

Also Published As

Publication number Publication date
CN104471399B (en) 2017-05-03
WO2013171446A3 (en) 2014-01-09
GB2518311A (en) 2015-03-18
GB2518311B (en) 2016-05-11
GB201208663D0 (en) 2012-06-27
CN104471399A (en) 2015-03-25

Similar Documents

Publication Publication Date Title
US6372513B1 (en) Device and process for lateral flow saliva testing
US5981294A (en) Device for blood separation in a diagnostic device
EP0556202B1 (en) Improved ligand assay
US5423989A (en) Plasma forming device
US4526690A (en) Apparatus for nucleic acid quantification
JPH0664051B2 (en) Blood separation apparatus and method
US20170212108A1 (en) Device for rapid diagnostic tests to detect antigens with improved sensitivity
AU2009264774A1 (en) Porous solid phase for binding assay, and binding assay method using the same
CN111077309B (en) Immunoassay with capture conjugate
ATE421095T1 (en) POROSITY AND BIOLOGICAL ACTIVITY MAINTAINING ADHESIVE MEMBRANES IN AN ASSAY DEVICE FOR MEASUREMENT OF SERUM CHOLESTEROL IN ASSOCIATION WITH HIGH DENSITY LIPOPROTEINS
WO2016031892A1 (en) Immunochromatography test strip
WO2005079420A2 (en) Chromatographic exclusion agglutination assay and methods of use thereof
WO2011014673A1 (en) Automated lateral flow immunoassay cassette with improved flow properties
WO2017024297A1 (en) Multiplexed detection on microfluidic analytical devices
US20170212112A1 (en) Integration of sample separation with rapid diagnostic tests for improved sensitivity
WO2013171446A2 (en) Saliva testing
CN204807462U (en) Saliva sample chemical examination device
JP3560934B2 (en) Method and apparatus for separating plasma or serum from whole blood
JP4199607B2 (en) Immunochromatography test kit and immunochromatography test method
AU2001253291B2 (en) Device and process for lateral flow saliva testing
EP3427049A1 (en) An assay and kit for detection of endotoxin
US20210199547A1 (en) Methods and devices for hydrogel- and aerogel-based sample pretreatment
JP3544968B2 (en) Human hemoglobin detector
CN118202245A (en) Agglutinating agents, devices and methods for whole blood assays
AU2001253291A1 (en) Device and process for lateral flow saliva testing

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13733027

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 1422440

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20130517

WWE Wipo information: entry into national phase

Ref document number: 1422440.6

Country of ref document: GB

122 Ep: pct application non-entry in european phase

Ref document number: 13733027

Country of ref document: EP

Kind code of ref document: A2